Clinical Trial Update: Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update for bendamustine plus rituximab in Cold Agglutinin Disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hemolytic Anemia
• Cold Agglutinin Disease

Drugs mentioned

• Rituxan (rituximab)
• Treanda (Bendamustine)

Snippet

Sponsor: Helse Fonna | Conditions: Cold Agglutinin Disease, Autoimmune Hemolytic Anemia | Phase 2 | Status: COMPLETED